Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Elvira OG van Vliet, Elisabeth M Boormans, Thomas S de Lange, Ben W Mol & Martijn A Oudijk. (2014) Preterm labor: current pharmacotherapy options for tocolysis. Expert Opinion on Pharmacotherapy 15:6, pages 787-797.
Read now
Read now
Raphaël Favory, Diamantino R Salgado & Jean-Louis Vincent. (2009) Investigational vasopressin receptor modulators in the pipeline. Expert Opinion on Investigational Drugs 18:8, pages 1119-1131.
Read now
Read now
KY Ronald Kam & Ronald F Lamont. (2008) Developments in the pharmacotherapeutic management of spontaneous preterm labor. Expert Opinion on Pharmacotherapy 9:7, pages 1153-1168.
Read now
Read now
Mats Åkerlund. (2006) Targeting the oxytocin receptor to relax the myometrium. Expert Opinion on Therapeutic Targets 10:3, pages 423-427.
Read now
Read now
Articles from other publishers (26)
Annie R. A. McDougall, Roxanne Hastie, Maya Goldstein, Andrew Tuttle, Anne Ammerdorffer, A. Metin Gülmezoglu & Joshua P. Vogel. (2023) New medicines for spontaneous preterm birth prevention and preterm labour management: landscape analysis of the medicine development pipeline. BMC Pregnancy and Childbirth 23:1.
Crossref
Crossref
Megan A. Opichka, M. Christine Livergood, Justin L. Grobe & Jennifer J. McIntosh. 2023. Cardiovascular Neuroendocrinology. Cardiovascular Neuroendocrinology
111
135
.
Ahmed Haider, Zhiwei Xiao, Xiaotian Xia, Jiahui Chen, Richard S. Van, Shi Kuang, Chunyu Zhao, Jian Rong, Tuo Shao, Perla Ramesh, Appu Aravind, Yihan Shao, Chongzhao Ran, Larry J. Young & Steven H. Liang. (2021) Development of a triazolobenzodiazepine-based PET probe for subtype-selective vasopressin 1A receptor imaging. Pharmacological Research 173, pages 105886.
Crossref
Crossref
I. I. Khegay. (2021) Vasopressin Receptors in Blood Vessels and Proliferation of Endotheliocytes. Russian Journal of Bioorganic Chemistry 47:4, pages 815-827.
Crossref
Crossref
Samantha Sparapani, Cassandra Millet-Boureima, Joshua Oliver, Kathy Mu, Pegah Hadavi, Tamar Kalostian, Nazifa Ali, Carla Maria Avelar, Marion Bardies, Brenton Barrow, Minky Benedikt, Giuliana Biancardi, Raminder Bindra, Lisa Bui, Zakaria Chihab, Ashley Cossitt, Jeffrey Costa, Tina Daigneault, Jocelyn Dault, Isa Davidson, Jonathan Dias, Emie Dufour, Sabine El-Khoury, Nargess Farhangdoost, Anika Forget, Alexa Fox, Myriam Gebrael, Maria Concetta Gentile, Olivia Geraci, Ansley Gnanapragasam, Elias Gomah, Elie Haber, Claudia Hamel, Thivya Iyanker, Christina Kalantzis, Sara Kamali, Elsa Kassardjian, Hryssi Krissy Kontos, Thi Bich Uyen Le, Daniella LoScerbo, Yan Fang Low, Danielle Mac Rae, Flore Maurer, Sana Mazhar, Alice Nguyen, Kathy Nguyen-Duong, Chelsea Osborne-Laroche, Hwi Wun Park, Emilie Parolin, Kahlila Paul-Cole, Leah Sarah Peer, Margaux Philippon, Charles-Alexandre Plaisir, Jessica Porras Marroquin, Simran Prasad, Rewaparsad Ramsarun, Saad Razzaq, Samantha Rhainds, Damien Robin, Ryan Scartozzi, Davindra Singh, Sajad Soleimani Fard, Maxim Soroko, Nastaran Soroori Motlagh, Kiri Stern, Laila Toro, M. Wyatt Toure, Stephanie Tran-Huynh, Sarah Trépanier-Chicoine, Claudia Waddingham, Aaliyah Jasmine Weekes, Allison Wisniewski & Chiara Gamberi. (2021) The Biology of Vasopressin. Biomedicines 9:1, pages 89.
Crossref
Crossref
Beatrix Stadler, Michael R. Whittaker, Betty Exintaris & Ralf Middendorff. (2020) Oxytocin in the Male Reproductive Tract; The Therapeutic Potential of Oxytocin-Agonists and-Antagonists. Frontiers in Endocrinology 11.
Crossref
Crossref
Gábor Szántó, Attila Makó, Ferenc Baska, Éva Bozó, Katalin Domány-Kovács, Dalma Kurkó, Attila Cselenyák, Réka Mohácsi, Krisztina Szondiné Kordás & Imre Bata. (2020) New V1a receptor antagonist. Part 1. Synthesis and SAR development of urea derivatives. Bioorganic & Medicinal Chemistry Letters 30:18, pages 127416.
Crossref
Crossref
Kazimierz Wiśniewski. 2019. Cyclic Peptide Design. Cyclic Peptide Design
235
271
.
William E. Scorza, Sharon Maynard & Anthony Scardella. 2018. Critical Care Obstetrics. Critical Care Obstetrics
87
114
.
V. I. Tsirkin, S. I. Trukhina, A. N. Trukhin, S. V. Khlybova & K. Yu. Anisimov. (2018) Oxytocin receptor antagonists and their clinical application. Rossiiskii vestnik akushera-ginekologa 18:5, pages 16.
Crossref
Crossref
Jie Li, Yang Chen, Anran Wang & Haiying Zhang. (2017) A meta-analysis of atosiban supplementation among patients undergoing assisted reproduction. Archives of Gynecology and Obstetrics 296:4, pages 623-634.
Crossref
Crossref
T. GEORGIEV, A. TOLEKOVA, R. KALFIN & P. HADZHIBOZHEVA. (2017) Short-Term Administration of Melatonin or Ghrelin on Diabetic Rats: Effects on Angiotensin II and Vasopressin–Induced Uterine Contractility. Physiological Research, pages 125-133.
Crossref
Crossref
Vicki Flenady, Hanna E Reinebrant, Helen G Liley, Eashan G Tambimuttu & Dimitri NM Papatsonis. (2014) Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Vicki Flenady, Aleena M Wojcieszek, Dimitri NM Papatsonis, Owen M Stock, Linda Murray, Luke A Jardine & Bruno Carbonne. (2014) Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database of Systematic Reviews.
Crossref
Crossref
S. Arrowsmith & S. Wray. (2014) Oxytocin: Its Mechanism of Action and Receptor Signalling in the Myometrium. Journal of Neuroendocrinology 26:6, pages 356-369.
Crossref
Crossref
Taka-aki Koshimizu, Kazuaki Nakamura, Nobuaki Egashira, Masami Hiroyama, Hiroshi Nonoguchi & Akito Tanoue. (2012) Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems. Physiological Reviews 92:4, pages 1813-1864.
Crossref
Crossref
Rachel Russell, Rachel Doyle, Jamie Turner, Neil Attkins, Simeon Ramsey, Laura Weibley, Lucy Bateman, Magda Bictash, Stevie Neal-Morgan, Magnus Ivarsson & Nick Pullen. (2011) In vitro and in vivo pharmacological characterisation of the potent and selective vasopressin V1A receptor antagonist 4-[4-(4-Chloro-phenyl)-5-[1,2,3]triazol-2-ylmethyl-4H-[1,2,4]triazol-3-yl]-piperidin-1-yl-(3,5-difluoro-phenyl) methanone (PF-00738245). European Journal of Pharmacology 670:2-3, pages 347-355.
Crossref
Crossref
Nikolaos Vrachnis, Fotodotis M. Malamas, Stavros Sifakis, Efthymios Deligeoroglou & Zoe Iliodromiti. (2011) The Oxytocin-Oxytocin Receptor System and Its Antagonists as Tocolytic Agents. International Journal of Endocrinology 2011, pages 1-8.
Crossref
Crossref
Piotr Pierzynski. (2011) Oxytocin and vasopressin V1A receptors as new therapeutic targets in assisted reproduction. Reproductive BioMedicine Online 22:1, pages 9-16.
Crossref
Crossref
William E. Scorza & Anthony Scardella. 2010. Critical Care Obstetrics. Critical Care Obstetrics
69
92
.
Carles Villabona. (2010) Antagonistas del receptor de vasopresina: los vaptanes. Endocrinología y Nutrición 57, pages 41-52.
Crossref
Crossref
Natalie F. Holt & Kenneth L. Haspel. (2010) Vasopressin: A Review of Therapeutic Applications. Journal of Cardiothoracic and Vascular Anesthesia 24:2, pages 330-347.
Crossref
Crossref
Steven Thornton, Thomas M. Goodwin, Gorm Greisen, Morten Hedegaard & Joan-Carles Arce. (2009) The effect of barusiban, a selective oxytocin antagonist, in threatened preterm labor at late gestational age: a randomized, double-blind, placebo-controlled trial. American Journal of Obstetrics and Gynecology 200:6, pages 627.e1-627.e10.
Crossref
Crossref
Guy Decaux, Alain Soupart & Gilbert Vassart. (2008) Non-peptide arginine-vasopressin antagonists: the vaptans. The Lancet 371:9624, pages 1624-1632.
Crossref
Crossref
. 2006. Arzneiverordnung in Schwangerschaft und Stillzeit. Arzneiverordnung in Schwangerschaft und Stillzeit
33
557
.
Dimitri Papatsonis, Vicki Flenady, Stephen Cole & Helen Liley. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.